LACHENAIE, QC,
June 19, 2012 /PRNewswire/ -
Capital Pro-Égaux Inc. (the "Company") reports that on
Thursday June 14th,
2012, the "Company" has filed, through its wholly owned subsidiary
Technique d'usinage Sinlab Inc., notices against Nobel Biocare
USA, Nobel Biocare Procera
USA, Dentsply International Inc,
Cagenix Technologies Inc, Materialise Dental Inc, BioHorizons
Global HQ, DelCam Holdings and DelCam USA Inc for patent infringement of the
"Company" United States Patent Nos. 8,021,153, 7,866,980,
7,331,786, 6,814,575 and 6,382,975.
This notice, amongst various requests, formally requires to
immediately ceasing the manufacturing and the selling of
manufacturing programs of the superstructure and/or the surgical
guide for dental implant placement covered by the patents and to
respond in writing by no later than the 5th of July 2012, 17:00 hours. Failure to comply will
generate immediate legal proceedings
About Pro-Égaux Inc.
Pro-Égaux through its wholly owned subsidiary, Technique d'usinage
Sinlab Inc., is a company based in Lachenaie, Quebec, specializing mainly in the
conception and design of titanium products to be used in the dental
prosthesis restoration industry.
"Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release."
SOURCE CAPITAL PRO-EGAUX INC.